002940.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 03:04):

Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules...

Stats
Today's Volume	1.63M
Average Volume	1.57M
Market Cap	3.21B
EPS	CNY0 ( 2023-10-27 )
Next earnings date	( CNY0 ) 2024-05-15
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	23.14
ATR14	CNY0.0220 (0.14%)

Volume Correlation

Long: -0.04 (neutral)

Short: -0.38 (neutral)

Signal:(44.05) Neutral

Zhejiang AngLiKang Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhejiang AngLiKang Correlation - Currency/Commodity

-0.21
( neutral )

-0.31
( neutral )

0.00
( neutral )

-0.45
( neutral )

-0.39
( neutral )

Zhejiang AngLiKang Financials

Annual	2023
Revenue:	CNY1.63B
Gross Profit:	CNY725.36M (44.61 %)
EPS:	CNY0.690

FY	2023
Revenue:	CNY1.63B
Gross Profit:	CNY725.36M (44.61 %)
EPS:	CNY0.690

FY	2022
Revenue:	CNY1.57B
Gross Profit:	CNY897.89M (57.25 %)
EPS:	CNY0.640

FY	2021
Revenue:	CNY1.38B
Gross Profit:	CNY892.62M (64.66 %)
EPS:	CNY1.270

Financial Reports:

No articles found.

Zhejiang AngLiKang

Zhejiang Anglikang Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The company offers products in anti-infection, antihypertensive, digestive system, and respiratory preparation. It is also involved in research and development of drugs for featuring oral cephalosporins, cardiovascular, kidney, and central nervous diseases. The company was founded in 2001 and is based in Shengzhou, China.